What is Retatrutide? Retatrutide is a Triple-Receptor Agonist. It acts on three hormone receptors-GLP-1, GIP, Glucagon- to regulate metabolism, appetite, and energy balance.

How is Retatrutide being researched? Retatrutide is a researched peptide currently be studied for its powerful effects on weight management, blood sugar control, cardio metabolic benefits, and liver fat reduction. It targets three key metabolic pathways and has shown significant results in early clinical trails. Up to 24% body weight reduction over 48 week. Improved insulin sensitivity and metabolism. Studies are investigating potential benefits in conditions like nonalcoholic fatty liver disease and chronic kidney disease. Reductions in triglycerides apoC-III levels, it studies. Phase 3 trails are underway to evaluate long-term efficacy and safety.